Skip to main content
. 2017 May 3;12(5):e0177198. doi: 10.1371/journal.pone.0177198

Fig 2. IL-6 reduced the expression of PCAT29 in prostate cancer but not normal cells.

Fig 2

DU145 and LNCaP cells were treated with IL-6 (10 ng/ml) for 24 h, following which the expression of PCAT29 was determined by real-time RT-PCR. Both DU145 and LNCaP cells showed decreased PCAT29 expression after IL-6 treatment. There was no difference in PCAT29 expression following IL-6 treatment in RWPE-1 cells. Data are presented as the mean ± SEM of at least 3 independent samples. Asterisks (*) indicates statistically significantly difference (p < 0.05) from vehicle groups.